The kidney contains blood pressure-lowering substances, such as prostaglandin E2 or prostaglandin A2, and blood pressure-raising substances such as thromboxane A2. Most of the postulated substances, however,
Introduction
In 1898 an aqueous extract from the kidney was found to have a pressor effect (1) . Many years later, this discovery led to detailed investigation and elucidation of both the components and the mode of action of the renin-angiotensin-aldosterone system, and since that time the kidney has been recognized as the principal blood pressure-regulating organ of the body. This was followed by the observations that stable hypertension can be induced by inducing ischemia (2) or by wrapping the kidney in cellophane (3) .
Although Rauwolfia serpentina roots had been used in India for the treatment of high blood pressure since 1931 (4), the drug was not used in the West until the mid-fifties. The treatment of high blood pressure remained difficult long after the introduction of hydralazine, which was the first drug that allowed effective treatment of this severe condition. Therefore, great interest arose in 1940, when Page et al. (5) reported that renal extracts given to patients with malignant hypertension caused regression of the changes in their optic fundi and lowered their high blood pressure. This prompted numerous attempts to isolate vasoactive substances from the kidney (6−10) . Experiments in dogs showed that renoprival hypertension could be alleviated by intraperitoneal administration of macerated renal medulla but not by intraperitoneal administration of macerated renal cortex (11) , and it was clear that the blood pressure-lowering active principle must be located in the renal medulla. This ultimately led to isolation of the powerful vasodilator substances prostaglandin A2 and E2 from the renal medulla (12) .
However, there is evidence that not all the substances present in or secreted by the kidney have yet been identified. For example, renal vein effluate from an isolated perfused kidney has been shown to lower the blood pressure of spontaneously hypertensive rats, and the blood pressure reduction is directly proportional to the perfusion pressure (13) . Because of its unique attributes, such as its abolition by excluding the liver from the circulation (14) , by previous administration of proadifen (15) , or by mixing the extract with Tween 20 or butyl boric acid (16) , this blood pressure-lowering activity cannot be ascribed to any previously known substance.
Recently, tremendous progress has been made regarding the role of vasoactive hormonal peptides such as adrenomedullin (17) , angiotensin (18) , endothelin (19) , or thrombomodulin (20) . In contrast, over the same time period progress has been very slow in the characterization and isolation of non-peptidic vasoactive substances such as medullipin or the endogenous digitalis-like factor (21) , and accordingly, in the determination of their role in cardiovascular physiology. In the course of investigating vasoactive, nonpeptidic substances from the kidney medulla, a strong blood pressureincreasing activity was unexpectedly detected. Since a similar activity has not been described before, the aim of the present research was to further characterize this previously unknown active pressor principle from the kidney.
Methods

Drugs and Chemicals Applied
Potassium chloride, sodium chloride, calcium chloride, potassium dihydrogenphosphate, magnesium sulfate, sodium hydrogencarbonate, edetate calcium disodium, acetylcholine chloride, serotonin, norepinephrine chloride, and sodium nitroprusside dihydrate were obtained from Sigma Chemicals Inc. (Deisenhofen, Germany). All organic solvents used were of analytical grade and were obtained from Riedel De Haen (Seelze, Germany). For preparation of aqueous solutions, aqua bidestillata was used. In organ chambers, dissection baths and laboratory equipment Duran ® glass and laboratory equipment made of Duran ® glass (Schott, Mainz, Germany)
were employed throughout.
The Raw Material
The source material consisted of pig kidneys. About 15 min after slaughtering and immediately after the meat inspection, the kidneys were excised with a knife from the lung-liver-kidney block as it passed along the conveyor belt, and were immediately placed in crushed ice. Not more than 45 min later they were snap-frozen in liquid nitrogen and stored at -40°C until dissection. The kidneys were longitudinally sectioned at 2−3 mm thickness using an electric slicing machine (Graef, Germany). The kidney slices were carefully dissected with a scalpel so as to separate the medulla from the cortex and renal pelvis. The medulla was immediately placed in liquid nitrogen. This material was again stored at -40°C.
Further Treatment of the Renal Medulla
The renal medulla was then pulverized in the liquid nitrogencooled steel bowl of a kitchen mixer (Vorwerk Thermomix 3300, Wuppertal, Germany). Subsequent freeze-drying of the powder was carried out by Suwelack Inc. (Billerbeck, Germany). Active fractions (1-276)
Extraction
The lyophilizate was transferred to a 20-l beaker (Schott, Mainz, Germany). Chloroform was added and the material was mixed for about 10 min with a mixing machine (UltraTurrax T50; Janke and Kunkel, Staufen, Germany) at maximum speed. The solid material was exhaustively extracted with nine successive portions of chloroform until it became colorless. The obtained solution was evaporated to dryness in vacuo at room temperature, leaving a dark yellowish viscous oil that was free of peptides and proteins. For biological test purposes, an aliquot portion of the solution was set aside for the animal experiments. After adding a small amount of chloroform, the remaining extract was applied to 259.9 g of silica gel (ICN, Eschwege, Germany) having an irregular grain of size 32−64 μm and a pore size of 60 Å, and transferred to a desiccator to remove the chloroform in vacuo. The yield was 464 g of dry powder. 
Silica Gel Chromatography
Gel Chromatography
The last two combined fractions, D and E, were further separated by gel chromatography on a Sephadex LH-20 column (Fluka, Buchs, Switzerland 
Further Separations
In the course of preliminary feasibility studies pursuant to the isolation of medullopressin, countercurrent chromatography, gradient VLC, and medium pressure liquid chromatograpy were performed. In all cases, the pressor activity continued to be observed after the chromatography. 
Preparation of Samples for Animal Testing
Mixtures Employed and Dosages
The combined fraction E/1−276, containing the activity, and for comparison the combined fraction D/1−48, also as described above, were each tested in seven rats, together with the solvent control. The volume was 1.5 ml, and the injection was given over about 10 s. In each instance the dose was 10 mg/kg body weight.
Tissue Preparation
Bovine and porcine hearts were obtained from the slaughterhouse. They were excised immediately after withdrawal of the organ package, rinsed with cold (4°C) Krebs-solution, then filled with this solution and cooled down to 1−4°C. Dissection of the coronary arteries was carried out in a KrebsRinger bicarbonate solution (4°C; mmol/l: CaCl2, 2.5; KCl, 4.7; KH2HPO4, 1.2; MgSO4, 1.2, NaCl, 118,6; NaHCO3, 25.1; calcium disodium EDTA, 0.026; glucose, 11.1). Aortas were excised from slain laboratory mice (CRL:
after pentobarbital anesthesia (50 mg/kg body weight pentobarbital intraperitoneally) with the aid of a magnifier. The vessel was filled with Krebs-Ringer bicarbonate solution (4°C) as soon as possible, isolated, removed and placed into a 4°C tempered Krebs-Ringer bath (pH 7.3), and dissected under a microscope (Wild-Heerbrugg, Switzerland). Vessel rings were suspended in the organ chambers from fine tungsten stirrups of different diameters as appropriate. The study design and protocols were in accordance with the institutional animal care committee and the American Heart Association Guidelines for Research Animal Use.
Vascular Function
Aortic and coronary artery rings were suspended from the tungsten holders in organ chambers containing 10 ml of Krebs-bicarbonate solution (37°C, pH 7.4, 95% O2 and 5% CO2). They were equilibrated for 1 h. The resting tension was gradually increased. Rings were repeatedly exposed to 100 mmol/l KCl until the optimal tension for generation of force during isometric contraction was reached. Precontraction was not different between groups and contractions upon KCl exposure did not differ significantly between the groups. After equilibration for 30 min, rings were precontracted with 100 mmol/l KCl again, until a stable plateau was reached. Doses of 50 μg/ml medullopressin or control solution, respectively, were applied. Constriction experiments with norepinephrine and serotonin, respectively, and relaxation experiments with acetylcholine (1 × 10 -10 -3 × 10 -5 mol/l) and sodium nitroprusside (1 × 10 -10 -3 × 10 -5 mol/l) were subsequently performed, in order to demonstrate that the rings were vital. The endothelium was proven to be functional after the experiments. The dimensions of the arterial rings used in this study did not differ significantly. Due to the small amounts of fractions, blocking experiments with pretreatment of vascular rings by specific blocking agents, i.e., 20-hydroxyeicosatetraenoic acid blockers, or different angiotensin blockers and endothelin blockers, respectively, could not be performed.
Animal Experiments
For the animal experiments, 21 adult spontaneously hypertensive rats were used. These were Wistar rats (SHR/N Crl BR) with an average weight of about 400 g obtained from Charles River (Sulzbach, Germany). Under ketanest−diazepam anesthesia (ketanest 50 mg/kg body weight; diazepam 3 mg/kg body weight), each of the extracts was injected over approximately 10 s via the jugular vein. The dose was set to 50 mg/ kg body weight, so as to conform with the procedure of Lee et al. (10) . Blood pressure was measured intra-arterially, access being gained via the right femoral artery. We used a pressure converter (Becton Dickinson, Lincoln Park, USA) in conjunction with a Siemens Sirecust 404 monitor (Siemens, Blood pressure increase (mmHg) 
Data Analysis, Statistics and Protocol Design
All data are given as the means±SD. Relaxations are expressed as absolute values in g, and as a percentage of precontractions. Contractions to medullopressin were normalized to the maximal contractile response to 100 mmol/l KCl. Due to the very limited quantity of medullopressin, the determination of EC50 could not be achieved in the present study.
The maximum blood pressure readings at the peak point were compared with the blood pressure readings immediately before injection of the mixtures. Blood pressure-measuring protocols and vascular ring tension-measuring protocols were primarily designed and approved for detection of blood pressure-lowering activities. This was the rationale for testing the "medullopressin" extract after precontraction with KCl. The Mann-Whitney U-test was used where appropriate, with the aid of the program Graph Pad Prism (Graph Pad, San Diego, USA). A p value < 0.05 was considered to indicate statistical significance.
Results
Preliminary Physicochemical Characterization of Medullopressin
From the extraction conditions and chromatographic parameters, the following can be concluded regarding the chemical and physicochemical characteristics of medullopressin. It is extractable from the renal medulla, but not from the renal cortex, when using chloroform. Within the polarity range covered by chloroform extracts, medullopressin is rather polar and behaves like a neutral lipid. Its molecular weight is less than 2,000 D and its chromatographic behavior indicates that it is a small molecule. Medullopressin is stable at neutral to moderately acidic pH, as well as within a temperature range from -196 to at least 50°C. Because presently medullopressin is not a single chemical entity amenable to MS or NMR analysis, the average dosage was estimated for a single constituent based on HPLC and TLC profiling to be in the few μg/kg body weight range or below, which corresponds to typical physiological concentrations of hormonal substances.
Blood Pressure Characteristics
By means of the spontaneously hypertensive Wistar rat model, the activities of the active fraction, an inactive comparison fraction and a control solvent were evaluated as follows (Fig. 2) . The combined fraction E/1−276 (active fraction) showed powerful blood pressure-elevating activity, reaching its peak 55±27 s after ending the injection and lasting for 201±59 s. An example of this short lasting blood pressure rise is shown in Fig. 2a . As can be seen, the blood pressure rises almost immediately after starting the injection, continues to rise, reaches a peak, and finally falls back somewhat more slowly to reach its original level after ca. 10 min. The rise amounted to 30.1±7.1 mmHg in systolic blood pressure (SBP) and 34.7±6 mmHg in diastolic blood pressure (DBP) (p= 0.0003). After injection of a inactive comparison fraction D/1−48 there was no substantial change in the blood pressure. A typical blood pressure curve is shown in Fig. 2b . At the time point at which the blood pressure peak was produced by injection of the active fraction E/1−276, i.e., 55 s after the end of the injection, there was only a slight rise in SBP of 1.1±3 mmHg, and a slight rise in DBP of 0.3 ±5.1 mmHg. None of these increases were statistically significant. After injection of the solvent control, i.e., the mixture of ethanol−water used for suspending the fractions, there was again no significant change in blood pressure. A typical example of the blood pressure curve is shown in Fig. 2c . At the corresponding time point of the blood pressure peak produced by injection of the active combined fraction E/1−276, i.e., 55 s after the end of the injection, there was a slight rise in SBP of 0.1±3 mmHg, and a slight rise in DBP of 0.9±2.2 mmHg. These differences were again of no statistical significance.
The maximum blood pressure increase caused by the active combined fraction E/1−276 (Fig. 3) was 30.1±7.1 mmHg systolic and 34.7±6 mmHg diastolic, respectively, and was significantly different compared to both the fraction D/1−48 (p= 0.0003) and the solvent control (p= 0.0003). After injection of an analogous extract and fractions from renal cortex, no significant change in blood pressure was observed.
Vascular Function
In bovine coronary artery vessels (n= 15), cumulative contraction upon exposure to 10 -6 mol/l serotonin was 2.1±0.8 g. Contractions did not differ significantly between the control (n= 8) and the medullopressin group (n= 7, data not shown). The relaxation in response to 10 -6 mol/l acetylcholine was -1.8±0.6 g, and did not differ significantly between the groups. In porcine coronary artery vessels, the results resembled those for the bovine vessels, with strong contractions and relaxations, respectively, upon exposure to acetylcholine, norepinephrine and sodium nitroprusside. Data were not analyzed statistically (n= 4). Table 1 shows the extent of precontraction in the aorta of mice in the control and medullopressin group, the contractile responses to 100 mmol/l potassium chloride and norepinephrine, and the relaxing response upon exposure to acetylcholine (data are given in g as absolute values). Acetylcholine relaxation almost completely abolished the contractile response to norepinephrine after the medullopressin and the control experiments. There was no statistical difference between the two groups, showing that the aortic rings were fully vital at the end of the experimental protocol. Figure 4 shows a typical vascular response to medullopressin in a bovine coronary artery; the response consisted of an additional contraction lasting for more than 1 h. The mean contractile response was 0.9±0.3, which was significantly different from that in the control group (p= 0.016; n= 7). Similar results were obtained in porcine coronary arteries. Figure  5 depicts the typical vascular response to medullopressin in the aortic rings of mice. The contractile response was much more pronounced compared to the effects in bovine and porcine coronary arteries. It accounted for 0.38±0.13 g, i.e., 31.9±10.9% of the maximum potassium contraction (Table  2 ; data are given as a percentage of the maximal potassium contraction and norepinephrine contraction, respectively). This value was markedly different from that of the control group (0.01±0.06; p= 0.008). Because all experiments were carried out using a stable potassium contraction, the maximum contraction upon injection of medullopressin was 1.58±0.45 g. This value differed markedly from the control value (1.04±0.37; p= 0.001), as well as from the maximum potassium contraction in the medullopressin group (1.19±0.41; p= 0.008). In contrast to the blood pressure response characteristics, the contractile response of blood vessels in both the coronary artery vessels and the aorta of mice lasted for more than 1 h, with the blood pressure peak being reflected in an early constriction response peak. Figure  6 shows the constriction response characteristics within the first 80 min after application of medullopressin to the aortic rings of mice (n= 11).
Vascular Response to Medullopressin
Discussion
In this paper we describe a powerful blood pressure increase, lasting only a few minutes and commencing immediately after the injection of a fractionated chloroform extract of renal medulla. No change in blood pressure was observed after injection of the solvent control, indicating that the aforementioned activity cannot be ascribed to a volume effect. A relatively large injection volume (1.5 ml) was needed to meet pharmaceutical requirements in terms of galenic quality. The blood pressure response cannot be a non-specific effect due to injection of a fat emulsion, because injection of the comparison fractions did not induce any such blood pressure rise. Also, such changes in blood pressure have never been reported in experiments with fractions prepared from extracts of renal medulla made by a similar (22, 23) or any other processing. Furthermore, as we were able to enrich the activity in the combined fraction D/1−276, all the evidence indicates that this activity must be due to a substance present in the mixture. Even after injection of other suspensions of fatty fractions we have never found any activity of the kind described above. A slight rise in blood pressure immediately after the injection was also observed in some experiments with the crude extract and in an experiment with the fraction E (= 47−73) obtained after the initial separation on the silica gel column.
The blood pressure increasing activity described here was due to an immediate contraction of the arterial blood vessels, as shown in the aorta of mice as well as in porcine and bovine coronary arteries. Surprisingly, the constricting response lasted for more than 1 h in every single vessel ring that was examined. The difference in the duration of the blood pressure and vascular response, respectively, could not be explained by the interspecies differences among rats, mice, pigs and cows. Due to the limited quantity of material, further pharmacological characterization of the compound could not be performed. This point merits further investigation.
In earlier studies by Vincent and Sheen (24) , and Thauer (25) , an activity similar to that of medullopressin was not observed. This matches our observation that a similar pressor activity is not present in the kidney cortex, and supports the conclusion that it is specific to the kidney medulla.
Ever since Tigerstedt and Bergmann first reported a blood pressure-elevating activity, which was eventually attributed to renin, in the kidney in 1898 (1), and following the observation of blood pressure-lowering activity in the kidneys and muscle by Page et al. in 1940 (5) , there have been numerous attempts to isolate and describe vasoactive substances derived from the renal medulla or cortex or from renal vein effluate. These substances and mixtures can be classified into those that lower blood pressure, and those that raise it. Among the endogenous blood pressure-lowering substances are the following. 1) Powerful vasodilator prostaglandins, such as prostaglandin E2 and A2 (12) , and diuretic prostaglandins such as prostaglandin F2α (26): These prostaglandins are present in significant amounts in the renal medulla and constitute a very important blood pressure-lowering component of the medulla (12) . The vasodilator and blood pressure-lowering actions of these substances begin immediately after injection and continue for some minutes (27) . 2) Phospholipid renin inhibitors such as those isolated from dog kidneys (28), and subsequently described synthetic substances such as lysophosphatidyl ethanolamine analogues (29) : Both are capable of lowering the blood pressure of hypertensive rats. 3) A chemically modified lipid from the renal medulla known as antihypertensive polar renomedullary lipid (APRL): APRL is an extraordinarily powerful vasodilator; its effect begins immediately after injection and lasts for 30−60 min (23) . APRL was characterized as a mixture of alkyl ether analogues of phosphatidyl choline (23). 4) A presumably neutral lipid present in the renal medulla that was given the name antihypertensive neutral renomedullary lipid (ANRL) by analogy with the polar lipid (23) . Its activity does not commence until a few minutes after injection, but may last for several hours (23) .
On the other hand, mixtures or substances that raise blood pressure have been described as follows. 1) The previously mentioned work by Tigerstedt led to the isolation of renin (30) , which, however, exerts no action on the blood vessels itself.
2) The blood pressure-raising peptide corticotensin was reported to be present in the pig renal cortex (31), but has not yet been isolated. 3) Renopressin is another protein that was found to be present in the pig renal cortex (8) . The authors demonstrated that a preparation obtained from renin-free pig renal cortex caused a slow rise in blood pressure, and that this reaction was not antagonized by an angiotensin II blocker (8). 4) Several authors have claimed that urine contains a pressor substance (32−34) . This substance is thought to be a protein with a molecular weight of 25,000 D. Upon long-term administration it causes hypertrophy of the suprarenal cortex. The blood pressure rises, as do plasma aldosterone and the urine K + /Na + ratio, indicating a Na + -retaining property of the compound (35, 36) . 5) The blood pressure-elevating activity of the protein nephrotensin has been identified in the venous effluate from ischemic kidneys (37−39) . This protein has been assigned to be angiotensin I bound to α-2-globulin (40). However, the activity differs from the activity of angiotensin I and angiotensin II in rats (38) .
In addition to the aforementioned five hypertensive entities there have been certain attempts to obtain pressor substances from the kidney, or to identify the activity of mixtures obtained from plasma originating from the kidney (41−43). However, none of these mixtures can possibly explain the extensive blood pressure rise observed in this study. All of the previously described substances are proteins, some of them with high molecular weights. Since the Sephadex LH-20 separation step employed in the present study excluded all particles above 2,000 amu, any sizeable peptide, including every endothelin, would have been eluted with the solvent front, which had been discarded.
In contrast, medullopressin was obtained using pure chloroform for extraction of the renal medulla. This corresponds to the method of lipid extraction and purification used by Bligh and Dyer (44), and does not yield extracts of intact proteins or peptides. The latter method starts with a monophasic mixture of homogenized tissue fluid, methanol, and chloroform, from which a biphasic mixture is produced by adding water and chloroform, so that the chloroform layer contains the lipids and the methanol−water layer contains all the other substances. Similarly, the chloroform extraction of the present study leads to isolation of the lipids and their separation from any proteins present. The method provides a reduced yield of lipids, whereas the extraction method by Bligh and Dyer (44) is specifically designed to optimize the total extractable lipid yield (w/w), regardless of biological activity. However, this was not the goal of the present study. In preliminary experiments, the yield of medullopressin activity when using the Bligh and Dyer method was not higher than that when using straight chloroform for extraction. Therefore, an exhaustive maceration in chloroform was chosen as the extraction method.
Also excluded from consideration as active pressor substances are the prostanoid substances present in extremely large amounts in the renal medulla (12) . These prostaglandins isolated from the renal medulla, namely prostaglandin E2 and A2, are among the most potent known vasodilator agents, and therefore cannot account for the activity observed here. Additionally, they were ruled out by GC-MS. The only remaining potential candidate with known pressor activity is thromboxane A2, an endogenous peroxide derived from arachidonic acid. Its blood pressure elevating property compares closely in extent and duration with the newly discovered agent, medullopressin. This applies especially to the rapid blood pressure rise that follows administration of thromboxane A2 (45) . However, because of its poor stability⎯thromboxane A2 has a half life of only about 30 s at room temperature (46)⎯this prostaglandin is much too unstable to survive the chromatography, sample preparation and processing conditions of this study and, therefore, falls out of consideration.
Moreover, the method of lipid extraction that has been employed to isolate the prostaglandins from the renal medulla has to be considered in the discussion of potential candidates for the active principle (26) . As Lee explained (47), the purpose of the extraction method is the exclusion of the neutral lipids, the preservation of the acidic prostaglandins, and their separation from the neutral lipids. The first step was to extract the acidified aqueous homogenate of the renal medulla with methylene chloride. This extract was expected to contain both the acid and the neutral lipids. The methylene chloride phase was then extracted by shaking with phosphate buffer, the idea being that only the acid lipids would pass into the buffer, while the neutral lipids would remain behind. The phosphate buffer was then acidified and extracted again with methylene chloride; the organic phase now contained the activity, which later led to the discovery of the prostaglandins in the kidney (26) . However, the original methylene chloride extract contained an activity that was later described by Muirhead (22) as the ANRL activity mentioned above. Because Muirhead's extract is a representative example of a prostaglandin-free extract, our extract was prepared in the same manner. If the present extract had contained any known prostanoid substances, an activity attributable to one of these substances would have been observed, in keeping with Lee's work. However, we did not observe any such activity. While the renal medulla has been shown to contain considerable amounts of prostaglandins, especially vasodilator prostaglandins, we have found no blood pressure-related activity attributable to these substances. In the case that prostaglandins had been present in the extract, it also seems very unlikely, from a physicochemical perspective, that any blood pressure-elevating prostaglandins or thromboxanes would have been present in the fraction due to their lipophilicity. Because these substances are quite non-polar organic molecules, they most likely would have been eluted with the solvent front (i.e., the discarded "fraction 0") under the given chromatographic conditions, but certainly before fraction A, and not with fractions D or E, which represent the polar end of the gradient elution scheme. In summary, the results presented above demonstrate that porcine renal medulla contains a lipid, which we have designated medullopressin, that is a very potent blood pressure-raising agent. To the best of our knowledge, so far no comparable blood pressure-elevating substance from the kidney has been described in the literature.
